Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 33
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide

  • López-Valero, Israel
  • Saiz-Ladera, Cristina
  • Torres, Sofía
  • Hernández-Tiedra, Sonia
  • García-Taboada, Elena
  • Rodríguez-Fornés, Fátima
  • Barba, Marina
  • Dávila, David
  • Salvador-Tormo, Nélida
  • Guzmán Pastor, Manuel
  • Sepúlveda, Juan Manuel
  • Sánchez-Gómez, Pilar
  • Lorente Pérez, María Del Mar
  • Velasco Díez, Guillermo
Glioblastoma multiforme (GBM) is the most frequent and aggressive type of brain tumor due, at least in part, to its poor response to current anticancer treatments. These features could be explained, at least partially, by the presence within the tumor mass of a small population of cells termed Glioma Initiating Cells (GICs) that has been proposed to be responsible for the relapses occurring in this disease. Thus, the development of novel therapeutic approaches (and specifically those targeting the population of GICs) is urgently needed to improve the survival of the patients suffering this devastating disease. Previous observations by our group and others have shown that Δ9-Tetrahydrocannabinol (THC, the main active ingredient of marijuana) and other cannabinoids including cannabidiol (CBD) exert antitumoral actions in several animal models of cancer, including gliomas. We also found that the administration of THC (or of THC + CBD at a 1:1 ratio) in combination with temozolomide (TMZ), the benchmark agent for the treatment of GBM, synergistically reduces the growth of glioma xenografts. In this work we investigated the effect of the combination of TMZ and THC:CBD mixtures containing different ratios of the two cannabinoids in preclinical glioma models, including those derived from GICs. Our findings show that TMZ + THC:CBD combinations containing a higher proportion of CDB (but not TMZ + CBD alone) produce a similar antitumoral effect as the administration of TMZ together with THC and CBD at a 1:1 ratio in xenografts generated with glioma cell lines. In addition, we also found that the administration of TMZ + THC:CBD at a 1:1 ratio reduced the growth of orthotopic xenografts generated with GICs derived from GBM patients and enhanced the survival of the animals bearing these intracranial xenografts. Remarkably, the antitumoral effect observed in GICs-derived xenografts was stronger when TMZ was administered together with cannabinoid combinations containing a higher proportion of CBD. These findings support the notion that the administration of TMZ together with THC:CBD combinations – and specifically those containing a higher proportion of CBD – may be therapeutically explored to target the population of GICs in GBM.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Correction, ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer (BMC Cancer, (2024), 24, 1, (876), 10.1186/s12885-024-12501-5)

  • Leary, Alexandra
  • Estévez-García, Purificación
  • Sabatier, Renaud
  • Ray-Coquard, Isabelle|||0000-0003-2472-8306
  • Romeo, Margarita|||0000-0003-1725-8115
  • Barretina-Ginesta, Maria-Pilar|||0000-0003-0074-6614
  • Gil-Martin, Marta|||0000-0002-8548-5355
  • Garralda, Elena|||0000-0002-4412-7842
  • Bosch-Barrera, J.|||0000-0002-0893-7821
  • Morán, Teresa
  • Martin-Martorell, Paloma
  • Nadal, Ernest|||0000-0002-9674-5554
  • Gascón, Pere|||0000-0001-9690-9873
  • Rodon Ahnert, Jordi|||0000-0001-6467-3632
  • Lizcano de Vega, José Miguel|||0000-0002-3154-5383
  • Muñoz-Guardiola, Pau|||0000-0002-0741-4463
  • Fierro-Durán, Gemma
  • Pedrós-Gámez, Oriol
  • Pérez-Montoyo, Hector
  • Yeste-Velasco, Marc|||0000-0001-7788-0913
  • Cortal, Marc
  • Perez Campos, Antonio
  • Alfón, José|||0000-0002-1874-0184
  • Domenech, Carles|||0000-0002-2817-3750
  • Pérez-Fidalgo, Alejandro
  • Oaknin, Ana|||0000-0002-3592-7194
Following publication of the original article [1], the authors reported the the equal contribution statement was missing in the original submission. The correct equal contribution statement is: Alejandro Pérez-Fidalgo and Ana Oaknin contributed equally to this work.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

  • Leary, Alexandra
  • Estévez-García, Purificación
  • Sabatier, Renaud
  • Ray-Coquard, Isabelle|||0000-0003-2472-8306
  • Romeo, Margarita|||0000-0003-1725-8115
  • Barretina-Ginesta, Maria-Pilar|||0000-0003-0074-6614
  • Gil-Martin, Marta|||0000-0002-8548-5355
  • Garralda, Elena|||0000-0002-4412-7842
  • Bosch-Barrera, J.|||0000-0002-0893-7821
  • Morán, Teresa
  • Martin-Martorell, Paloma
  • Nadal, Ernest|||0000-0002-9674-5554
  • Gascón, Pere|||0000-0001-9690-9873
  • Rodon Ahnert, Jordi|||0000-0001-6467-3632
  • Lizcano de Vega, José Miguel|||0000-0002-3154-5383
  • Muñoz-Guardiola, Pau|||0000-0002-0741-4463
  • Fierro-Durán, Gemma
  • Pedrós-Gámez, Oriol
  • Pérez-Montoyo, Hector
  • Yeste-Velasco, Marc|||0000-0001-7788-0913
  • Cortal, Marc
  • Perez Campos, Antonio
  • Alfón, José|||0000-0002-1874-0184
  • Domenech, Carles|||0000-0002-2817-3750
  • Pérez-Fidalgo, Alejandro
  • Oaknin, Ana|||0000-0002-3592-7194
Background: Carboplatin and paclitaxel (CP) have been the standard of care for advanced/recurrent endometrial cancer (EC) for many years. However, this chemotherapy combination shows limited efficacy and recurrences often occur in less than 12 months. ABTL0812 is a novel drug that selectively kill cancer cells by cytotoxic autophagy and has shown anticancer efficacy in preclinical models of EC in combination with CP. Methods: ENDOLUNG was an open-label, phase 1/2 clinical trial designed to determine the safety and efficacy of Ibrilatazar (ABTL0812) with CP in patients with advanced/recurrent EC and non-irradiable stage III and IV squamous non-small cell lung cancer (sq-NSCLC). The phase 1 part consisted of a 3 + 3 de-escalation design followed by an expansion cohort with 12 patients. The primary endpoint was safety. ABTL0812 starting dose was 1300 mg tid combined with carboplatin at area under the curve (AUC) 5 and paclitaxel at 175 mg/m both administered every 21 days for up to 8 cycles. The phase 2 part included a total of 51 patients. The primary endpoint was overall response rate (ORR) and the secondary endpoints included duration of response (DOR), progression-free survival (PFS) and overall survival (OS). Results: During the phase 1 only one dose limiting toxicity (DLT), a grade 4 neutropenia, was observed in 1 out of 6 patients, thus no de-escalation was applied. One additional DLT, a grade 3 febrile neutropenia, was observed in the expansion cohort, thus the recommended phase 2 dose (RP2D) for ABTL0812 was established at 1300 mg tid. Most frequent hematological adverse events (AE) of the combination were neutropenia (52.9%), anemia (37.3%) and thrombocytopenia (19.6%). Nausea (66.7%), asthenia (66.7%), diarrhea (54.9%) and vomiting (54.9%) were the most frequent non-hematological adverse events (AEs). The combination of ABTL0812 plus CP showed an ORR of 65.8% (13.2% complete response and 52.6% partial response) with a median DOR of 7.4 months (95% CI: 6.3-10.8 months). Median PFS was 9.8 months (95% CI: 6.6-10.6) and median OS 23.6 months (95% CI 6.4-ND). Pharmacokinetic parameters were compatible with target engagement observed in preclinical studies, and blood pharmacodynamic biomarkers indicated sustained target regulation during, at least, 28 days after starting the treatment. Conclusions: This study suggests that the combination of ABTL0812 with CP is safe and feasible with an encouraging activity in patients with advanced/recurrent EC. Our data warrant further confirmation in prospective randomized trials. Trial registration: EU Clinical Trial Register, EudraCT number 2016-001352-21 and National Clinical Trials Number, NCT03366480. Registration on 19 September 2016.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive analysis of the relationship between ultra-processed food consumption and food addiction at one-year follow-up in older adults with metabolic syndrome

  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Vázquez-Lorente, Héctor|||0000-0003-0183-6902
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Gomis-González, Maria|||0000-0001-9778-4849
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
BACKGROUND: Ultra-processed foods (UPFs) are theorised to exhibit addictive properties within the framework of the Food Addiction (FA) model, attributable to their high palatability, sugars, salt, saturated/trans fats, and caloric density. AIMS: To evaluate the association between UPFs consumption and FA presence, and to examine whether reducing UPFs intake after one year of intervention is associated to decreased FA scores. METHODS: The sample included 429 Mediterranean older adults with overweight/obesity and metabolic syndrome from the PREDIMED-Plus-Cognition sub-study. FA presence was evaluated with the Yale Food Addiction Scale 2.0, and the nutritional information through validated food frequency questionnaires. UPFs was categorised according to the NOVA system and divided into consumption tertiles. Data were analysed using repeated measures ANOVA, structural equation modelling, and logistic regression to compare FA changes across tertiles of UPF reduction after one-year follow-up. RESULTS: Baseline YFAS categorisation into three levels (positive-probable-negative) showed significant differences between the second and third tertile of UPFs consumption, with the highest tertile of consumption having greater likelihood of worse FA status. After one year, the likelihood of change in the FA levels was higher only for individuals within the highest decreases in the UPFs consumption (OR = 1.67, p = 0.040). DISCUSSION AND CONCLUSIONS: These findings indicate that a reduction in the consumption of UPFs may contribute to the improvement of FA symptoms, providing novel insights into the association between UPFs and the presence of FA. Future research should focus on populations with higher UPFs consumption and investigating the long-term effects of dietary quality on FA symptoms.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A p120-catenin-CK1epsilon complex regulates Wnt signaling

  • Casagolda, David
  • Valle Pérez, Beatriz del
  • Valls, Gabriela
  • Lugilde, Ero
  • Vinyoles, Meritxell
  • Casado Vela, Juan
  • Solanas, Guiomar
  • Batlle Gómez, Eduard
  • Reynolds, Albert B.
  • Casal, José Ignacio
  • García de Herreros, Antonio
  • Duñach, Mireia
p120-catenin is an E-cadherin-associated protein that modulates E-cadherin function and stability. We describe here that p120-catenin is required for Wnt pathway signaling. p120-catenin binds and is phosphorylated by CK1ε in response to Wnt3a. p120-catenin also associates to the Wnt co-receptor LRP5/6, an interaction mediated by E-cadherin, showing an unexpected physical link between adherens junctions and a Wnt receptor. Depletion of p120-catenin abolishes CK1ε binding to LRP5/6 and prevents CK1ε activation upon Wnt3a stimulation. Elimination of p120-catenin also inhibits early responses to Wnt, such as LRP5/6 and Dvl-2 phosphorylation and axin recruitment to the signalosome, as well as later effects, such as β-catenin stabilization. Moreover, since CK1ε is also required for E-cadherin phosphorylation, a modification that decreases the affinity for β-catenin, p120-catenin depletion prevents the increase in β-catenin transcriptional activity even in the absence of β-catenin degradation. Therefore, these results demonstrate a novel and crucial function of p120-catenin in Wnt signaling and unveil additional points of regulation by this factor of β-catenin transcriptional activity different of β-catenin stability., This study was supported by grants awarded by the Ministerio de Ciencia e Innovación: BFU2006-03203 and BFU2009-07578 to M.D. and SAF2006-00339 to A.G.H. Partial support from the Instituto Carlos III (RD06/0020/0040) and the Generalitat de Catalunya (2009SGR867 and 2009SGR585) is also appreciated. D.C. and G.V. were supported by predoctoral fellowships from the Ministerio de Educación and E.L., from the UAB.
Repisalud
Publication Artículo científico (JournalArticle)

Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide

  • López-Valero, Israel
  • Saiz-Ladera, Cristina
  • Torres, Sofía
  • Hernández-Tiedra, Sonia
  • García-Taboada, Elena
  • Rodríguez-Fornés, Fátima
  • Barba, Marina
  • Dávila, David
  • Salvador-Tormo, Nélida
  • Guzmán, Manuel
  • Sepúlveda, Juan M
  • Sánchez-Gómez, Pilar
  • Lorente, Mar
  • Velasco, Guillermo
Glioblastoma multiforme (GBM) is the most frequent and aggressive type of brain tumor due, at least in part, to its poor response to current anticancer treatments. These features could be explained, at least partially, by the presence within the tumor mass of a small population of cells termed Glioma Initiating Cells (GICs) that has been proposed to be responsible for the relapses occurring in this disease. Thus, the development of novel therapeutic approaches (and specifically those targeting the population of GICs) is urgently needed to improve the survival of the patients suffering this devastating disease. Previous observations by our group and others have shown that Δ9-Tetrahydrocannabinol (THC, the main active ingredient of marijuana) and other cannabinoids including cannabidiol (CBD) exert antitumoral actions in several animal models of cancer, including gliomas. We also found that the administration of THC (or of THC + CBD at a 1:1 ratio) in combination with temozolomide (TMZ), the benchmark agent for the treatment of GBM, synergistically reduces the growth of glioma xenografts. In this work we investigated the effect of the combination of TMZ and THC:CBD mixtures containing different ratios of the two cannabinoids in preclinical glioma models, including those derived from GICs. Our findings show that TMZ + THC:CBD combinations containing a higher proportion of CDB (but not TMZ + CBD alone) produce a similar antitumoral effect as the administration of TMZ together with THC and CBD at a 1:1 ratio in xenografts generated with glioma cell lines. In addition, we also found that the administration of TMZ + THC:CBD at a 1:1 ratio reduced the growth of orthotopic xenografts generated with GICs derived from GBM patients and enhanced the survival of the animals bearing these intracranial xenografts. Remarkably, the antitumoral effect observed in GICs-derived xenografts was stronger when TMZ was administered together with cannabinoid combinations containing a higher proportion of CBD. These findings support the notion that the administration of TMZ together with THC:CBD combinations - and specifically those containing a higher proportion of CBD - may be therapeutically explored to target the population of GICs in GBM.
Repisalud
Publication Artículo científico (JournalArticle)

Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

  • Calvo-Silveria, Sara
  • González-Díaz, Aida
  • Grau, Inmaculada
  • Marimón, José María
  • Cercenado, Emilia
  • Quesada, M Dolores
  • Casabella, Antonio
  • Larrosa, Nieves
  • Yuste, Jose Enrique
  • Berbel, Dàmaris
  • Alonso, Marta
  • Tubau, Fe
  • Belman, Sophie
  • Cadenas-Jiménez, Irene
  • Martin-Galiano, Antonio Javier
  • Domínguez, María Ángeles
  • Martí, Sara
  • Liñares, Josefina
  • Pallarés, Román
  • Càmara, Jordi
  • Ardanuy, Carmen
Background: Invasive pneumococcal disease due to serotype 3 (S3-IPD) is associated with high mortality rates and long-term adverse effects. The introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into the Spanish paediatric immunisation programme has not led to a decrease in the adult S3-IPD. We aimed to analyse the incidence, clinical characteristics and genomics of S3-IPD in adults in Spain. Methods: Adult IPD episodes hospitalized in a Southern Barcelona hospital were prospectively collected (1994-2020). For genomic comparison, S3-IPD isolates from six Spanish hospitals (2008-2020) and historical isolates (1989-1993) were analysed by WGS (Illumina and/or MinION). Findings: From 1994 to 2020, 270 S3-IPD episodes were detected. When comparing pre-PCV (1994-2001) and late-PCV13 (2016-2020) periods, only modest changes in S3-IPD were observed (from 1.58 to 1.28 episodes per 100,000 inhabitants year). In this period, the incidence of the two main lineages shifted from 0.38 to 0.67 (CC180-GPSC12) and from 1.18 to 0.55 (CC260-GPSC83). The overall 30-day mortality remained high (24.1%), though a decrease was observed between the pre-PCV (32.4%; 95.0% CI, 22.0-45.0) and the late-PCV13 period (16.7%; 95.0% CI, 7.5-32.0) (p = 0.06). At the same time, comorbidities increased from 77.3% (95.0% CI, 65.0-86.0) to 85.7% (95.0% CI, 71.0-94.0) (p = 0.69). There were no differences in clinical characteristics or 30-day mortality between the two S3 lineages. Although both lineages were genetically homogeneous, the CC180-GPSC12 lineage presented a higher SNP density, a more open pan-genome, and a major presence of prophages and mobile genetic elements carrying resistance genes. Interpretation: Adult S3-IPD remained stable in our area over the study period despite PCV13 introduction in children. However, a clonal shift was observed. The decrease in mortality rates and the increase in comorbidities suggest a change in clinical management and overall population characteristics. The low genetic variability and absence of clinical differences between lineages highlight the role of the S3 capsule in the disease severity.
Repisalud
Publication Artículo científico (JournalArticle)

Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs.

  • Maiques-Diaz, A
  • Chou, F S
  • Wunderlich, M
  • Gómez-López, G
  • Jacinto, F V
  • Rodriguez Perales, Sandra
  • Larrayoz, M J
  • Calasanz, M J
  • Mulloy, J C
  • Cigudosa, J C
  • Alvarez, S
The AML1-ETO fusion protein, which is present in 10-15% of cases of acute myeloid leukemia, is known to repress myeloid differentiation genes through DNA binding and recruitment of chromatin-modifying proteins and transcription factors in target genes. ChIP-chip analysis of human hematopoietic stem/progenitor cells transduced with the AML1-ETO fusion gene enabled us to identify 1168 AML1-ETO target genes, 103 of which were co-occupied by histone deacetylase 1 (HDAC1) and had lost the hyperacetylation mark at histone H4, and 264 showed a K9 trimethylation at histone H3. Enrichment of genes involved in hematopoietic differentiation and in specific signaling pathways was observed in the presence of these epigenetic modifications associated with an 'inactive' chromatin status. Furthermore, AML1-ETO target genes had a significant correlation between the chromatin marks studied and transcriptional silencing. Interestingly, AML1 binding sites were absent on a large number of selected AML1-ETO promoters and an Sp1 binding site was found in over 50% of them. Reversible silencing induced by the fusion protein in the presence of AML1 and/or Sp1 transcription factor binding site was confirmed. Therefore, this study provides a global analysis of AML1-ETO functional chromatin modifications and identifies the important role of Sp1 in the DNA binding pattern of AML1-ETO, suggesting a role for Sp1-targeted therapy in this leukemia subtype.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Unraveling a Biomass-Derived Multiphase Catalyst for the Dehydrogenative Coupling of Silanes with Alcohols under Aerobic Conditions

  • Sorribes-Terrés, Iván
  • Ventura-Espinosa, David
  • Assis, Marcelo
  • Martin, Santiago
  • Bettini, Jefferson
  • Longo, Elson
  • Mata, Jose A.
  • Andrés, Juan
  • Concepción Heydorn, Patricia|||0000-0003-2058-3103
[EN] Herein, a novel silver and chromium nanostructured N-doped carbonaceous material has been synthesized by a biomass-annealing approach using readily available chitosan as a raw material. The resulting catalyst AgCr@CN-800 has been applied for the dehydrogenative coupling reaction of various silanes with different alcohols to obtain the corresponding silyl ethers under aerobic and mild conditions. Besides excellent activity and selectivity, the as-prepared catalyst exhibits good stability and reusability. Characterization by X-ray diffraction, X-ray photo-electron spectroscopy, inductively coupled plasma mass spectrometry, and high-resolution transmission electron microscopy (TEM) in combination with careful examination of the structure with Cs-corrected high-angle annular dark-field scanning TEM revealed that the catalyst AgCr@CN-800 comprises Ag- and CrN-aggregated particles, as well as highly dispersed Ag-N-x and Cr-N-x sites embedded in N-doped graphitic structures. A comparative catalytic study using structure-related catalysts in combination with acid-leaching treatments has shown that the most active species are the Ag particles and that their activity is boosted by the presence of Cr-derived species. By in situ Raman spectroscopy experiments, it has been found that the dehydrogenative coupling of silanes with alcohols in the presence of catalyst AgCr@CN-800 takes place through an oxygen-assisted mechanism., The authors thank the financial support from MICIU/AEI/FEDER (PGC2018-094417-B-I00 and RTI2018-098237-B-C22) and Universitat Jaume I (UJI-A2019-16, UJI-B2019-30, and UJI-B2018-23). I.S. thanks the Spanish Ministerio de Economia, Industria y Competitividad (MINECO) for a postdoctoral "Juan de la Cierva-Incorporacion" fellowship (IJCI-2016-30590), and the financial support from the "Jose Castillejo" Mobility Program (CAS19/00339) of the Ministerio de Ciencia, Innovacion y Universidades (MICIU). S.M. acknowledges DGA/fondos FEDER (construyendo Europa desde Aragon) for funding the research group Platon (E31_17R). D.V.-E. thanks the MICIU for a FPU grant (FPU15/03011). E.L. and M.A. thank the financial support from FAPESP (2013/07296-2), CNPq (166281/2017-4), CAPES, and FINEP. The authors also thank the "Servei Central d'Instrumentacio Cientifica (SCIC)" of the Universitat Jaume I, as well as Dr. G. Antorrena for technical support in XPS studies.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

  • García, S.
  • Pastor, R.
  • Monserrat-Mesquida, M.
  • Álvarez-Álvarez, L.
  • Rubín-García, M.
  • Martínez-González, M.Á.
  • Salas-Salvadó, J.
  • Corella, D.
  • Goday, A.
  • Martínez, J.A.
  • Alonso-Gómez, Ángel M.
  • Wärnberg, J.
  • Vioque, J.
  • Romaguera, D.
  • Lopez-Miranda, J.
  • Estruch, R.
  • Tinahones, F.J.
  • Lapetra, J.
  • Serra-Majem, L.
  • Riquelme-Gallego, B.
  • Pintó, X.
  • Gaforio, J.J.
  • Matía, P.
  • Vidal, J.
  • Vázquez, C.
  • Daimiel, L.
  • Ros, E.
  • Sayón-Orea, C.
  • Guillem-Saiz, P.
  • Valle-Hita, C.
  • Cabanes, R.
  • Abete, Itziar
  • Goicolea-Güemez, L.
  • Gómez-Gracia, E.
  • Tercero-Maciá, C.
  • Colom, A.
  • García-Ríos, A.
  • Castro-Barquero, S.
  • Fernández-García, J.C.
  • Santos-Lozano, J.M.
  • Cenoz, J.C.
  • Barragán, R.
  • Khoury, N.
  • Castañer, O.
  • Zulet, M.Á.
  • Vaquero-Luna, J.
  • Bes-Rastrollo, M.
  • de las Heras-Delgado, S.
  • Ciurana, R.
  • Martín-Sánchez, V.
  • Tur, J.A.
  • Bouzas, C.
[eng] Background: Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. Aims: To assess the association between MetS severity and amount of carbon dioxide (CO2) emitted in an adult population. Design: Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Methods: Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Results: Higher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions. Conclusions: Low CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga
  • Fiol, Miguel
  • Colom, Antoni
  • Martínez-González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Soria-Florido, María Trinidad
  • Martínez, J. Alfredo
  • Alonso-Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • López-Miranda, José
  • Estruch, Ramon
  • Bernal-López, M. Rosa
  • Lapetra, José
  • Serra-Majem, Lluís
  • Bueno-Cavanillas, Aurora
  • Tur, Josep A.
  • Martín Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Bes-Rastrollo, Maira
  • Pascual, María
  • Sorlí, Jose V.
  • Goday, Albert
  • Zulet, María Ángeles
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • Garcia-Rios, Antonio
  • Casas, Rosa
  • Gómez-Pérez, Ana M.
  • Santos-Lozano, José Manuel
  • Basterra-Gortari, F. Javier
  • Martínez, María Ángeles
  • Ortega-Azorin, Carolina
  • Bayó, Joan
  • Abete, Itziar
  • Salaverria-Lete, Itziar
  • Ruiz-Canela, Miguel
  • Babio, Nancy
  • Carres, Lourdes
  • Romaguera, Dora
[eng] Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p-values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS,
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial–mesenchymal transition

  • Beltrán, Manuel
  • Puig, Isabel
  • Peña Maroto, Cristina
  • García, José M.
  • Álvarez, Ana Belén
  • Peña, Raúl
  • Bonilla, Félix
  • García de Herreros, Antonio
Expression of Snail1 in epithelial cells triggers an epithelial–mesenchymal transition (EMT). Here, we demonstrate that the synthesis of Zeb2, a transcriptional repressor of E-cadherin, is up-regulated after Snail1-induced EMT. Snail1 does not affect the synthesis of Zeb2 mRNA, but prevents the processing of a large intron located in its 5′-untranslated region (UTR). This intron contains an internal ribosome entry site (IRES) necessary for the expression of Zeb2. Maintenance of 5′-UTR Zeb2 intron is dependent on the expression of a natural antisense transcript (NAT) that overlaps the 5′ splice site in the intron. Ectopic overexpression of this NAT in epithelial cells prevents splicing of the Zeb2 5′-UTR, increases the levels of Zeb2 protein, and consequently down-regulates E-cadherin mRNA and protein. The relevance of these results is demonstrated by the strong association between NAT presence and conservation of the 5′-UTR intron in cells that have undergone EMT or in human tumors with low E-cadherin expression. Therefore, the results presented in this article reveal the existence of a NAT capable of activating Zeb2 expression, explain the mechanism involved in this activation, and demonstrate that this NAT regulates E-cadherin expression., This study was supported by grants from the Ministerio de Educación y Ciencia (SAF2003-02324 and SAF2006-00339) and the Asociación Española contra el Cáncer (Catalunya contra el Càncer) to A.G.H. Partial support from the Instituto Carlos III (RD06/0020/0040) and from the Generalitat de Catalunya (2005SGR00970) is also appreciated. M.B. is a recipient of a predoctoral fellowship from the Instituto Carlos III., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A p120-catenin-CK1epsilon complex regulates Wnt signaling

  • Casagolda, David
  • Valle Pérez, Beatriz del
  • Valls, Gabriela
  • Lugilde, Ero
  • Vinyoles, Meritxell
  • Casado Vela, Juan
  • Solanas, Guiomar
  • Batlle Gómez, Eduard
  • Reynolds, Albert B.
  • Casal, José Ignacio
  • García de Herreros, Antonio
  • Duñach, Mireia
p120-catenin is an E-cadherin-associated protein that modulates E-cadherin function and stability. We describe here that p120-catenin is required for Wnt pathway signaling. p120-catenin binds and is phosphorylated by CK1ε in response to Wnt3a. p120-catenin also associates to the Wnt co-receptor LRP5/6, an interaction mediated by E-cadherin, showing an unexpected physical link between adherens junctions and a Wnt receptor. Depletion of p120-catenin abolishes CK1ε binding to LRP5/6 and prevents CK1ε activation upon Wnt3a stimulation. Elimination of p120-catenin also inhibits early responses to Wnt, such as LRP5/6 and Dvl-2 phosphorylation and axin recruitment to the signalosome, as well as later effects, such as β-catenin stabilization. Moreover, since CK1ε is also required for E-cadherin phosphorylation, a modification that decreases the affinity for β-catenin, p120-catenin depletion prevents the increase in β-catenin transcriptional activity even in the absence of β-catenin degradation. Therefore, these results demonstrate a novel and crucial function of p120-catenin in Wnt signaling and unveil additional points of regulation by this factor of β-catenin transcriptional activity different of β-catenin stability., This study was supported by grants awarded by the Ministerio de Ciencia e Innovación: BFU2006-03203 and BFU2009-07578 to M.D. and SAF2006-00339 to A.G.H. Partial support from the Instituto Carlos III (RD06/0020/0040) and the Generalitat de Catalunya (2009SGR867 and 2009SGR585) is also appreciated. D.C. and G.V. were supported by predoctoral fellowships from the Ministerio de Educación and E.L., from the UAB.
Docta Complutense
Publication Artículo científico (JournalArticle)

Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells

  • López Valero, Israel
  • Dávila, David
  • González Martínez, José
  • Salvador-Tormo, Nélida
  • Lorente Pérez, María Del Mar
  • Saiz Ladera, Cristina
  • Torres Pabón, Norma Sofía
  • Gabicagogeascoa Corta, Estíbaliz
  • Hernández-Tiedra, Sonia
  • García Taboada, Elena
  • Mendiburu-Eliçabe Garganta, Marina
  • Rodríguez Fornés, Fátima
  • Sánchez Domínguez, Rebeca
  • Segovia Martínez, Juan Carlos
  • Sánchez Gómez, Pilar
  • Matheu Fernández, Ander
  • Sepúlveda Salas, Juan Miguel
  • Velasco Díez, Guillermo
Glioblastoma (GBM) is one of the most aggressive forms of cancer. It has been proposed that the presence within these tumors of a population of cells with stem-like features termed Glioma Initiating Cells (GICs) is responsible for the relapses that take place in the patients with this disease. Targeting this cell population is therefore an issue of great therapeutic interest in neuro-oncology. We had previously found that the neurotrophic factor MIDKINE (MDK) promotes resistance to glioma cell death. The main objective of this work is therefore investigating the role of MDK in the regulation of GICs. Methods: Assays of gene and protein expression, self-renewal capacity, autophagy and apoptosis in cultures of GICs derived from GBM samples subjected to different treatments. Analysis of the growth of GICs-derived xenografts generated in mice upon blockade of the MDK and its receptor the ALK receptor tyrosine kinase (ALK) upon exposure to different treatments. Results: Genetic or pharmacological inhibition of MDK or ALK decreases the self-renewal and tumorigenic capacity of GICs via the autophagic degradation of the transcription factor SOX9. Blockade of the MDK/ALK axis in combination with temozolomide depletes the population of GICs in vitro and has a potent anticancer activity in xenografts derived from GICs. Conclusions: The MDK/ALK axis regulates the self-renewal capacity of GICs by controlling the autophagic degradation of the transcription factor SOX9. Inhibition of the MDK/ALK axis may be a therapeutic strategy to target GICs in GBM patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

  • Hermanova, Ivana
  • Zúñiga-García, Patricia
  • Caro-Maldonado, Alfredo|||0000-0002-5431-7949
  • Fernandez-Ruiz, Sonia
  • Salvador Velez, Fernando Maria|||0000-0002-0546-1354
  • Martín-Martín, Natalia|||0000-0002-2527-429X
  • Zabala-Letona, Amaia
  • Nuñez-Olle, Marc|||0000-0002-3593-2591
  • Torrano, Verónica
  • Camacho, Laura
  • Lizcano de Vega, José Miguel|||0000-0002-3154-5383
  • Talamillo, Ana
  • Carreira, Suzanne|||0000-0002-5077-5379
  • Gurel, Bora|||0000-0002-5018-8078
  • Cortazar, Ana Rosa|||0000-0002-7082-5695
  • Guiu, Marc|||0000-0002-7083-986X
  • López, Jose I.|||0000-0003-0842-5348
  • Martinez-Romero, Anabel
  • Astobiza, Ianire|||0000-0002-7142-7066
  • Valcarcel, Lorea|||0000-0002-7309-9924
  • Lorente, Mar|||0000-0003-0982-0956
  • Arruabarrena-Aristorena, Amaia|||0000-0002-1636-3944
  • Velasco, Guillermo|||0000-0002-1994-2386
  • Gomez Muñoz, Antonio|||0000-0002-2539-016X
  • Suárez-Cabrera, Cristian|||0000-0003-1897-1596
  • Lodewijk, Iris
  • Flores, Juana M.|||0000-0002-7995-4426
  • Sutherland, James D.|||0000-0003-3229-793X
  • Barrio, Rosa|||0000-0002-9663-0669
  • de Bono, Johann S.|||0000-0002-2034-595X
  • Paramio, Jesús M.|||0000-0001-7520-3177
  • Trka, Jan|||0000-0002-9527-8608
  • Graupera, Mariona|||0000-0003-4608-4185
  • Gomis, Roger R.|||0000-0001-6473-2858
  • Carracedo, Arkaitz|||0000-0001-5957-1260
This study unravels an unprecedented murine model of lethal metastatic prostate cancer, based on the combined deletion of Pten and Lkb1. Importantly, minimal activity of LKB1 is sufficient to hamper prostate cancer cell aggressiveness, thus redefining the relationship between gene dosage and tumor suppression. Gene dosage is a key defining factor to understand cancer pathogenesis and progression, which requires the development of experimental models that aid better deconstruction of the disease. Here, we model an aggressive form of prostate cancer and show the unconventional association of LKB1 dosage to prostate tumorigenesis. Whereas loss of Lkb1 alone in the murine prostate epithelium was inconsequential for tumorigenesis, its combination with an oncogenic insult, illustrated by Pten heterozygosity, elicited lethal metastatic prostate cancer. Despite the low frequency of LKB1 deletion in patients, this event was significantly enriched in lung metastasis. Modeling the role of LKB1 in cellular systems revealed that the residual activity retained in a reported kinase-dead form, LKB1 K78I, was sufficient to hamper tumor aggressiveness and metastatic dissemination. Our data suggest that prostate cells can function normally with low activity of LKB1, whereas its complete absence influences prostate cancer pathogenesis and dissemination.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Adopting a High-Polyphenolic Diet Is Associated with an Improved Glucose Profile, Prospective Analysis within the PREDIMED-Plus Trial

  • Tresserra-Rimbau, Anna|||0000-0002-7022-9041
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Babio, Nancy|||0000-0003-3527-5277
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • López-Miranda, José|||0000-0002-8844-0718
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Martín, Vicente|||0000-0003-0552-2804
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Fernández de la Puente, María
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Bullón-Vela, Vanessa|||0000-0003-3639-821X
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Gómez-Gracia, Enrique
  • Cases-Pérez, Eugenio
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casañas-Quintana, Tamara
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Santos-Lozano, José Manuel
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Bouzas, Cristina|||0000-0002-1407-8461
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Barragán, Rocío|||0000-0001-8072-3791
  • López Grau, Mercè
  • Razquín, Cristina|||0000-0003-3480-2645
  • Goicolea-Güemez, Leire
  • Toledo, Estefania|||0000-0002-6263-4434
  • Vergaz, Manel Vila
  • Lamuela-Raventós, Rosa M.|||0000-0002-1287-4560
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Previous studies suggested that dietary polyphenols could reduce the incidence and complications of type-2 diabetes (T2D); although the evidence is still limited and inconsistent. This work analyzes whether changing to a diet with a higher polyphenolic content is associated with an improved glucose profile. At baseline, and at 1 year of follow-up visits, 5921 participants (mean age 65.0 ± 4.9, 48.2% women) who had overweight/obesity and metabolic syndrome filled out a validated 143-item semi-quantitative food frequency questionnaire (FFQ), from which polyphenol intakes were calculated. Energy-adjusted total polyphenols and subclasses were categorized in tertiles of changes. Linear mixed-effect models with random intercepts (the recruitment centers) were used to assess associations between changes in polyphenol subclasses intake and 1-year plasma glucose or glycosylated hemoglobin (HbA1c) levels. Increments in total polyphenol intake and some classes were inversely associated with better glucose levels and HbA1c after one year of follow-up. These associations were modified when the analyses were run considering diabetes status separately. To our knowledge, this is the first study to assess the relationship between changes in the intake of all polyphenolic groups and T2D-related parameters in a senior population with T2D or at high-risk of developing T2D.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inflammatory potential of diet and bone mineral density in a senior Mediterranean population, a cross-sectional analysis of PREDIMED-Plus study

  • García-Gavilán, Jesús F.
  • Paz-Graniel, Indira
  • Babio, Nancy|||0000-0003-3527-5277
  • Romaguera, Dora|||0000-0002-5762-8558
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Martín, Vicente|||0000-0003-0552-2804
  • Martínez, María Ángeles
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • de Paz, José Antonio|||0000-0002-4389-1777
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Bulló, Mònica|||0000-0002-0218-7046
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Inflammation could play a key role in tissue damage and bone metabolism. The modified dietary inflammatory score (M-DIS) is a validated tool to estimate the inflammatory potential of the diet. In the present study, we evaluate the associations between the M-DIS and bone mineral density (BMD) in a senior Mediterranean population with overweight/obesity and metabolic syndrome. Baseline cross-sectional association between the M-DIS and bone mineral density was assessed in 1134 participants of the multicenter PREDIMED-Plus trial (aged 55-75 with overweight/obesity and metabolic syndrome). BMD was measured using Dual-energy X-ray Absorptiometry scans and participants answered a food frequency questionnaire to determine the M-DIS. BMD was categorized as low BMD when T score was equal or lower than -1 and normal BMD in another case. Associations between BMD and M-DIS were evaluated by using linear and logistic regressions adjusted by other co-variates. Participants in the top tertile of the M-DIS had a lower BMD at total femur [β (95% CI) - 0.02 (- 0.04, - 0.01)], trochanter areas [β (95% CI) - 0.03 (- 0.05, - 0.01)] and lumbar spine area [β (95% CI) - 0.03 (- 0.07, 0.01)] (but in the last case, measures were less precise and hence not statistically significant) compared to those in the lower M-DIS tertile. Multiple logistic regression analyses showed that the odds of the total femur and femoral trochanter osteopenia/osteoporosis were higher in participants in the top tertile compared to those in the lowest tertile of M-DIS [OR (95% CI) 1.71 (1.12, 2.64), P for trend 0.015; 2.02 (1.29, 3.21), P for trend 0.002, respectively]. A high pro-inflammatory diet, measured by the M-DIS, is associated with lower BMD in a senior Mediterranean population with metabolic syndrome. The online version contains supplementary material available at 10.1007/s00394-021-02751-5.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Fiol-Sala, Miquel
  • Colom, Antoni|||0000-0001-5041-0778
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Soria-Florido, María Trinidad|||0000-0002-5625-9033
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Pascual, María
  • Sorlí, José V.|||0000-0002-0130-2006
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Gómez Pérez, Ana María|||0000-0002-2874-5894
  • Santos-Lozano, José Manuel
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Martínez, María Ángeles
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Bayó, Joan
  • Abete, Itziar|||0000-0002-6475-5387
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Babio, Nancy|||0000-0003-3527-5277
  • Carres, Lourdes
  • Romaguera, Dora|||0000-0002-5762-8558
Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p -values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

  • Testa, Giulia|||0000-0003-4200-8062
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Mora-Maltas, Bernat|||0000-0002-4142-3208
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Granero, Roser|||0000-0001-6308-3198
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Babio, Nancy|||0000-0003-3527-5277
  • Fernández-Carrión, Rebeca
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Ni, Jiaqi
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Impulsivity has been associated with type 2 diabetes (T2D) and may negatively impact its management. This study aimed to investigate impulsive personality traits in an older adult population with T2D and their predicting role in long-term weight control and glycemic management, through glycated hemoglobin (HbA), following 3 years of intervention with a Mediterranean diet. The Impulsive Behavior Scale (UPPS-P) was administered as a measure of impulsive traits at baseline. Results showed higher total baseline scores of UPPS-P, and higher positive urgency in individuals with T2D, compared with those without T2D. The regression analysis in patients with T2D showed that sensation seeking and lack of perseverance predicted weight loss at follow-up. By contrast, impulsive traits did not predict follow-up levels of HbA. In conclusion, the present findings suggest that higher impulsive traits in individuals with T2D seem to affect long-term weight control, but not glycemic control.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Carbon dioxide (CO) emissions and adherence to Mediterranean diet in an adult population, the Mediterranean diet index as a pollution level index

  • García, Silvia
  • Bouzas, Cristina|||0000-0002-1407-8461
  • Mateos, David
  • Pastor, Rosario
  • Álvarez, Laura
  • Rubín, María
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Lopez-Miranda, José
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Guillem-Saiz, Patricia
  • Nishi, Stephanie
  • Cabanes, Robert
  • Abete, Itziar|||0000-0002-6475-5387
  • Goicolea-Güemez, Leire
  • Gómez-Gracia, Enrique
  • Signes-Pastor, Antonio José
  • Colom, Antoni|||0000-0001-5041-0778
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Vázquez, Zenaida
  • Sorlí, José V.|||0000-0002-0130-2006
  • Pascual, Maria
  • Castañer, Olga|||0000-0003-3169-997X
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Babio, Nancy|||0000-0003-3527-5277
  • Ciurana, Ramon
  • Martín, Vicente|||0000-0003-0552-2804
  • Tur, Josep Antonio|||0000-0002-6940-0761
Research related to sustainable diets is is highly relevant to provide better understanding of the impact of dietary intake on the health and the environment. To assess the association between the adherence to an energy-restricted Mediterranean diet and the amount of CO emitted in an older adult population. Using a cross-sectional design, the association between the adherence to an energy-reduced Mediterranean Diet (erMedDiet) score and dietary CO emissions in 6646 participants was assessed. Food intake and adherence to the erMedDiet was assessed using validated food frequency questionnaire and 17-item Mediterranean questionnaire. Sociodemographic characteristics were documented. Environmental impact was calculated through greenhouse gas emissions estimations, specifically CO emissions of each participant diet per day, using a European database. Participants were distributed in quartiles according to their estimated CO emissions expressed in kg/day: Q1 (≤2.01 kg CO), Q2 (2.02-2.34 kg CO), Q3 (2.35-2.79 kg CO) and Q4 (≥2.80 kg CO). More men than women induced higher dietary levels of CO emissions. Participants reporting higher consumption of vegetables, fruits, legumes, nuts, whole cereals, preferring white meat, and having less consumption of red meat were mostly emitting less kg of CO through diet. Participants with higher adherence to the Mediterranean Diet showed lower odds for dietary CO emissions: Q2 (OR 0.87; 95%CI: 0.76-1.00), Q3 (OR 0.69; 95%CI: 0.69-0.79) and Q4 (OR 0.48; 95%CI: 0.42-0.55) vs Q1 (reference). The Mediterranean diet can be environmentally protective since the higher the adherence to the Mediterranean diet, the lower total dietary CO emissions. Mediterranean Diet index may be used as a pollution level index.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial

  • Díez-Ricote, Laura
  • San-Cristobal, Rodrigo
  • Concejo, M José
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J Alfredo
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Ros, Emilio|||0000-0002-2573-1294
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • García-Gavilán, Jesús F.
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • Martínez-Urbistondo, Diego
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • García Rodríguez, Antonio
  • Gómez-Bellvert, Nuria
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Bernal-López, Rosa M.
  • Santos-Lozano, José M.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Sorlí, José V.|||0000-0002-0130-2006
  • Murphy, Michelle
  • Gasulla, Griselda|||0000-0003-4018-5786
  • Micó, Víctor
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Goñi Ochandorena, Estibaliz
  • Babio, Nancy|||0000-0003-3527-5277
  • Herraiz, Xavier
  • Ordovás, José M.
  • Daimiel, Lidia|||0000-0001-9898-6629
Choline and betaine intakes have been related to cardiovascular health. We aimed to explore the relation between 1-y changes in dietary intake of choline or betaine and 1-y changes in cardiometabolic and renal function traits within the frame of the PREDIMED (PREvención con DIeta MEDiterránea)-Plus trial. We used baseline and 1-y follow-up data from 5613 participants (48.2% female and 51.8% male; mean ± SD age: 65.01 ± 4.91 y) to assess cardiometabolic traits, and 3367 participants to assess renal function, of the Spanish PREDIMED-Plus trial. Participants met ≥3 criteria of metabolic syndrome and had overweight or obesity [BMI (in kg/m 2) ≥27 and ≤40]. These criteria were similar to those of the PREDIMED parent study. Dietary intakes of choline and betaine were estimated from the FFQ. The greatest 1-y increase in dietary choline or betaine intake (quartile 4) was associated with improved serum glucose concentrations (-3.39 and -2.72 mg/dL for choline and betaine, respectively) and HbA1c levels (-0.10% for quartile 4 of either choline or betaine intake increase). Other significant changes associated with the greatest increase in choline or betaine intake were reduced body weight (-2.93 and -2.78 kg, respectively), BMI (-1.05 and -0.99, respectively), waist circumference (-3.37 and -3.26 cm, respectively), total cholesterol (-4.74 and -4.52 mg/dL, respectively), and LDL cholesterol (-4.30 and -4.16 mg/dL, respectively). Urine creatinine was reduced in quartile 4 of 1-y increase in choline or betaine intake (-5.42 and -5.74 mg/dL, respectively). Increases in dietary choline or betaine intakes were longitudinally related to improvements in cardiometabolic parameters. Markers of renal function were also slightly improved, and they require further investigation. This trial was registered at as ISRCTN89898870.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO) emissions in an adult population

  • García, Silvia
  • Pastor, Rosario
  • Monserrat-Mesquida, Margalida
  • Álvarez-Álvarez, Laura
  • Rubín-García, María
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Lopez-Miranda, José
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Guillem-Saiz, Patricia
  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Cabanes, Robert
  • Abete, Itziar|||0000-0002-6475-5387
  • Goicolea-Güemez, Leire
  • Gómez-Gracia, Enrique
  • Tercero-Maciá, Cristina
  • Colom, Antoni|||0000-0001-5041-0778
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Cenoz, Juan Carlos
  • Barragán, Rocío|||0000-0001-8072-3791
  • Khoury, Nadine
  • Castañer, Olga|||0000-0003-3169-997X
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Ciurana, Ramon
  • Martín, Vicente|||0000-0003-0552-2804
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Bouzas, Cristina|||0000-0002-1407-8461
Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. To assess the association between MetS severity and amount of carbon dioxide (CO) emitted in an adult population. Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Higher glycaemia levels were found in people with higher CO emissions. The risk of having high severe MetS was related to high CO emissions. Low CO emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet. ISRCTN, . Registered 05 September 2013.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome, The PREDIMED Plus Cohort

  • Martínez-Urbistondo, Diego
  • San Cristóbal, RodrigoSan
  • Villares, Paula
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Babio, Nancy|||0000-0003-3527-5277
  • Corella, Dolores|||0000-0002-2366-4104
  • Del Val García, José Luis|||0000-0002-0391-9368
  • Ordovás, José M.
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Marcos, Alba
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Bullón Vela, María Vanessa
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Masagué, Marta
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodríguez, Anai
  • Candela-García, Inma
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Juárez, Oscar Lecea
  • Martín, Paco
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Orea, María del Carmen Sayón
  • Megías, Isabel
  • Baltasar, Enric
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Daimiel, Lidia|||0000-0001-9898-6629
To evaluate the effect of Non-alcoholic fatty liver disease (NAFLD) status in the impact of lifestyle over Health-related quality of life (HRQoL) in patients with metabolic syndrome (MetS). Baseline and 1 year follow up data from the PREDIMED-plus cohort (men and women, 55-75 years old with overweight/obesity and MetS) were studied. Adherence to an energy-restricted Mediterranean Diet (er-MeDiet) and Physical Activity (PA) were assessed with a validated screeners. Hepatic steatosis index (HSI) was implemented to evaluate NAFLD while the SF-36 questionnaire provided HRQoL evaluation. Statistical analyses were performed to evaluate the influence of baseline NAFLD on HRQoL as affected by lifestyle during 1 year of follow up. Data from 5205 patients with mean age of 65 years and a 48% of female participants. Adjusted linear multivariate mixed regression models showed that patients with lower probability of NAFLD (HSI < 36 points) were more responsive to er-MeDiet (β 0.64 vs β 0.05 per er-MeDiet adherence point, p< 0.01) and PA (β 0.05 vs β 0.01 per MET-h/week, p = 0.001) than those with high probability for NAFLD in terms Physical SF-36 summary in the 1 year follow up. 10 points of er-MeDiet adherence and 50 MET-h/week were thresholds for a beneficial effect of lifestyle on HRQoL physical domain in patients with lower probability of NAFLD. The evaluation of NAFLD by the HSI index in patients with MetS might identify subjects with different prospective sensitivity to lifestyle changes in terms of physical HRQoL ().
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Longitudinal association of dietary acid load with kidney function decline in an older adult population with metabolic syndrome

  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Megías, Isabel
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Amengual-Galbarte, Angela
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • García-Arellano, Ana
  • Barragán, Rocío|||0000-0001-8072-3791
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Peña-Orihuela, Patricia J.
  • Asencio-Aznar, Alberto
  • Gómez-Gracia, Enrique
  • Martinez-Urbistondo, Diego
  • Morey, Marga
  • Casas, Rosa|||0000-0002-0211-9166
  • Garrido-Garrido, Eva María
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Damas-Fuentes, Miguel
  • Goñi, Estibaliz
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Castañer, Olga|||0000-0003-3169-997X
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Gisbert-Sellés, Cristina
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Schröder, Helmut|||0000-0003-2231-5081
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
Diets high in acid load may contribute to kidney function impairment. This study aimed to investigate the association between dietary acid load and 1-year changes in glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (UACR). Older adults with overweight/obesity and metabolic syndrome (mean age 65 ± 5 years, 48% women) from the PREDIMED-Plus study who had available data on eGFR (n = 5,874) or UACR (n = 3,639) at baseline and after 1 year of follow-up were included in this prospective analysis. Dietary acid load was estimated as potential renal acid load (PRAL) and net endogenous acid production (NEAP) at baseline from a food frequency questionnaire. Linear and logistic regression models were fitted to evaluate the associations between baseline tertiles of dietary acid load and kidney function outcomes. One year-changes in eGFR and UACR were set as the primary outcomes. We secondarily assessed ≥ 10% eGFR decline or ≥10% UACR increase. After multiple adjustments, individuals in the highest tertile of PRAL or NEAP showed higher one-year changes in eGFR (PRAL, β: -0.64 ml/min/1.73 m 2 ; 95% CI: -1.21 to -0.08 and NEAP, β: -0.56 ml/min/1.73 m 2 ; 95% CI: -1.13 to 0.01) compared to those in the lowest category. No associations with changes in UACR were found. Participants with higher levels of PRAL and NEAP had significantly higher odds of developing ≥10% eGFR decline (PRAL, OR: 1.28; 95% CI: 1.07-1.54 and NEAP, OR: 1.24; 95% CI: 1.03-1.50) and ≥10 % UACR increase (PRAL, OR: 1.23; 95% CI: 1.04-1.46) compared to individuals with lower dietary acid load. Higher PRAL and NEAP were associated with worse kidney function after 1 year of follow-up as measured by eGFR and UACR markers in an older Spanish population with overweight/obesity and metabolic syndrome.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis

  • Micó, Victor
  • San-Cristobal, Rodrigo
  • Martín, Roberto
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • García-Arellano, Ana
  • Pertusa-Martinez, Salvador
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Muñoz Bravo, Carlos
  • Schröder, Helmut|||0000-0003-2231-5081
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Gonzalez, Jose I.
  • Martinez-Urbistondo, Diego
  • Toledo, Estefania|||0000-0002-6263-4434
  • Bullón, Vanessa
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Portillo, María Puy
  • Macías-González, Manuel
  • Perez-Diaz-del-Campo, Nuria
  • García-Gavilán, Jesús
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Martínez, J Alfredo
Metabolic syndrome (MetS) is one of the most important medical problems around the world. Identification of patient's singular characteristic could help to reduce the clinical impact and facilitate individualized management. This study aimed to categorize MetS patients using phenotypical and clinical variables habitually collected during health check-ups of individuals considered to have high cardiovascular risk. The selected markers to categorize MetS participants included anthropometric variables as well as clinical data, biochemical parameters and prescribed pharmacological treatment. An exploratory factor analysis was carried out with a subsequent hierarchical cluster analysis using the z-scores from factor analysis. The first step identified three different factors. The first was determined by hypercholesterolemia and associated treatments, the second factor exhibited glycemic disorders and accompanying treatments and the third factor was characterized by hepatic enzymes. Subsequently four clusters of patients were identified, where cluster 1 was characterized by glucose disorders and treatments, cluster 2 presented mild MetS, cluster 3 presented exacerbated levels of hepatic enzymes and cluster 4 highlighted cholesterol and its associated treatments Interestingly, the liver status related cluster was characterized by higher protein consumption and cluster 4 with low polyunsaturated fatty acid intake. This research emphasized the potential clinical relevance of hepatic impairments in addition to MetS traditional characterization for precision and personalized management of MetS patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evolution of invasive pneumococcal disease by serotype 3 in adults, a Spanish three-decade retrospective study

  • Calvo-Silveria, Sara|||0000-0001-8448-6017
  • Gonzalez Diaz, Aida|||0000-0002-8326-1307
  • Grau, Inmaculada
  • Marimón, José María|||0000-0002-2787-7094
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Quesada, Maria Dolores|||0000-0001-8360-3787
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Larrosa, María Nieves|||0000-0001-8808-0233
  • Yuste, José|||0000-0001-7996-0837
  • Berbel, Dàmaris|||0000-0002-3689-3360
  • Alonso, Marta
  • Tubau, Fe|||0000-0002-6416-6451
  • Belman, Sophie
  • Cadenas-Jiménez, Irene|||0009-0003-0633-5784
  • Martín-Galiano, Antonio J.|||0000-0002-6662-329X
  • Domínguez, M.Ángeles
  • Marti, Sara|||0000-0002-0405-2305
  • Liñares Louzao, Josefina|||0000-0002-0855-6623
  • Pallarés, Román|||0000-0003-3262-8508
  • Càmara, Jordi|||0000-0002-0817-0931
  • Ardanuy, Carmen|||0000-0003-0225-607X
Background: Invasive pneumococcal disease due to serotype 3 (S3-IPD) is associated with high mortality rates and long-term adverse effects. The introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into the Spanish paediatric immunisation programme has not led to a decrease in the adult S3-IPD. We aimed to analyse the incidence, clinical characteristics and genomics of S3-IPD in adults in Spain. Methods: Adult IPD episodes hospitalized in a Southern Barcelona hospital were prospectively collected (1994-2020). For genomic comparison, S3-IPD isolates from six Spanish hospitals (2008-2020) and historical isolates (1989-1993) were analysed by WGS (Illumina and/or MinION). Findings: From 1994 to 2020, 270 S3-IPD episodes were detected. When comparing pre-PCV (1994-2001) and late-PCV13 (2016-2020) periods, only modest changes in S3-IPD were observed (from 1.58 to 1.28 episodes per 100,000 inhabitants year). In this period, the incidence of the two main lineages shifted from 0.38 to 0.67 (CC180-GPSC12) and from 1.18 to 0.55 (CC260-GPSC83). The overall 30-day mortality remained high (24.1%), though a decrease was observed between the pre-PCV (32.4%; 95.0% CI, 22.0-45.0) and the late-PCV13 period (16.7%; 95.0% CI, 7.5-32.0) (p = 0.06). At the same time, comorbidities increased from 77.3% (95.0% CI, 65.0-86.0) to 85.7% (95.0% CI, 71.0-94.0) (p = 0.69). There were no differences in clinical characteristics or 30-day mortality between the two S3 lineages. Although both lineages were genetically homogeneous, the CC180-GPSC12 lineage presented a higher SNP density, a more open pan-genome, and a major presence of prophages and mobile genetic elements carrying resistance genes. Interpretation: Adult S3-IPD remained stable in our area over the study period despite PCV13 introduction in children. However, a clonal shift was observed. The decrease in mortality rates and the increase in comorbidities suggest a change in clinical management and overall population characteristics. The low genetic variability and absence of clinical differences between lineages highlight the role of the S3 capsule in the disease severity. Funding: This study has been funded by Instituto de Salud Carlos III (ISCIII) "PI18/00339", "PI21/01000", "INT22/00096", "FI22/00279", CIBER "CIBERES-CB06/06/0037", "CIBERINFEC-CB21/13/00009" and MSD grant "IISP 60168".
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Associations Between the Modified Food Standard Agency Nutrient Profiling System Dietary Index and Cardiovascular Risk Factors in an Elderly Population

  • Khoury, Nadine
  • Gómez Donoso, Clara|||0000-0003-4753-3560
  • Martínez, María Ángeles
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • León-Acuña, Ana
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Santos-Lozano, JM.|||0000-0001-7097-5653
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Massó, Paloma|||0000-0002-3519-9254
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Barragán, Rocío|||0000-0001-8072-3791
  • Castañer, Olga|||0000-0003-3169-997X
  • Torres-Peña, Jose David
  • Notario Barandiaran, Leyre|||0000-0003-0517-6307
  • Muñoz-Bravo, Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Prohens, Lara
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Fernández García, José Carlos|||0000-0003-2308-2865
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Pascual, Maria
  • Sorlí, José V.|||0000-0002-0130-2006
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Peña-Orihuela, Patricia J.
  • Signes-Pastor, Antonio J.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Schröeder, Helmut
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
Background: Helping consumers to improve the nutritional quality of their diet is a key public health action to prevent cardiovascular diseases (CVDs). The modified version of the Food Standard Agency Nutrient Profiling System Dietary Index (FSAm-NPS DI) underpinning the Nutri-Score front-of-pack label has been used in public health strategies to address the deleterious consequences of poor diets. This study aimed to assess the association between the FSAm-NPS DI and some CVD risk factors including body mass index (BMI), waist circumference, plasma glucose levels, triglyceride levels, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and diastolic and systolic blood pressure. Materials and Methods: Dietary intake was assessed at baseline and after 1 year of follow-up using a 143-item validated semi-quantitative food-frequency questionnaire. Dietary indices based on FSAm-NPS applied at an individual level were computed to characterize the diet quality of 5,921 participants aged 55-75 years with overweight/obesity and metabolic syndrome from the PREDIMED-plus cohort. Associations between the FSAm-NPS DI and CVD risk factors were assessed using linear regression models. Results: Compared to participants with a higher nutritional quality of diet (measured by a lower FSAm-NPS DI at baseline or a decrease in FSAm-NPS DI after 1 year), those participants with a lower nutritional quality of diet (higher FSAm-NPS DI or an increase in score) showed a significant increase in the levels of plasma glucose, triglycerides, diastolic blood pressure, BMI, and waist circumference (β coefficient [95% confidence interval]; P for trend) (1.67 [0.43, 2.90]; <0.001; 6.27 [2.46, 10.09]; <0.001; 0.56 [0.08, 1.05]; 0.001; 0.51 [0.41, 0.60]; <0.001; 1.19 [0.89, 1.50]; <0.001, respectively). No significant associations in relation to changes in HDL and LDL-cholesterol nor with systolic blood pressure were shown. Conclusion: This prospective cohort study suggests that the consumption of food items with a higher FSAm-NPS DI is associated with increased levels of several major risk factors for CVD including adiposity, fasting plasma glucose, triglycerides, and diastolic blood pressure. However, results must be cautiously interpreted because no significant prospective associations were identified for critical CVD risk factors, such as HDL and LDL-cholesterol, and systolic blood pressure.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prospective associations between a priori dietary patterns adherence and kidney function in an elderly Mediterranean population at high cardiovascular risk

  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Ruiz García, Verónica|||0000-0002-7405-2319
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Rubín García, María|||0000-0003-0916-4215
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Toledo, Estefania|||0000-0002-6263-4434
  • Sorlí, José V.|||0000-0002-0130-2006
  • Roca, C.
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodriguez, Anai
  • Crespo-Oliva, Edelys
  • Candela-García, Inmaculada
  • Morey, Marga
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Fernández García, José Carlos|||0000-0003-2308-2865
  • Santos-Lozano, JM.|||0000-0001-7097-5653
  • Diez-Espino, Javier
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Comas, Mercè
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Sorto-Sanchez, Carolina
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
To assess the association between three different a priori dietary patterns adherence (17-item energy reduced-Mediterranean Diet (MedDiet), Trichopoulou-MedDiet and Dietary Approach to Stop Hypertension (DASH)), as well as the Protein Diet Score and kidney function decline after one year of follow-up in elderly individuals with overweight/obesity and metabolic syndrome (MetS). We prospectively analyzed 5675 participants (55-75 years) from the PREDIMED-Plus study. At baseline and at one year, we evaluated the creatinine-based estimated glomerular filtration rate (eGFR) and food-frequency questionnaires-derived dietary scores. Associations between four categories (decrease/maintenance and tertiles of increase) of each dietary pattern and changes in eGFR (ml/min/1.73m) or ≥ 10% eGFR decline were assessed by fitting multivariable linear or logistic regression models, as appropriate. Participants in the highest tertile of increase in 17-item erMedDiet Score showed higher upward changes in eGFR (β: 1.87 ml/min/1.73m; 95% CI: 1.00-2.73) and had lower odds of ≥ 10% eGFR decline (OR: 0.62; 95% CI: 0.47-0.82) compared to individuals in the decrease/maintenance category, while Trichopoulou-MedDiet and DASH Scores were not associated with any renal outcomes. Those in the highest tertile of increase in Protein Diet Score had greater downward changes in eGFR (β: - 0.87 ml/min/1.73m; 95% CI: - 1.73 to - 0.01) and 32% higher odds of eGFR decline (OR: 1.32; 95% CI: 1.00-1.75). Among elderly individuals with overweight/obesity and MetS, only higher upward change in the 17-item erMedDiet score adherence was associated with better kidney function after one year. However, increasing Protein Diet Score appeared to have an adverse impact on kidney health. Trial Registration Number: ISRCTN89898870 (Data of registration: 2014).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Deprivation Index and Lifestyle, Baseline Cross-Sectional Analysis of the PREDIMED-Plus Catalonia Study

  • Basora, Josep|||0000-0003-0278-1149
  • Villalobos, Felipe|||0000-0002-6907-8354
  • Pallejà-Millán, Meritxell|||0000-0003-1985-8894
  • Babio, Nancy|||0000-0003-3527-5277
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Pintó, Xavier|||0000-0002-2216-2444
  • Sacanella, Emilio|||0000-0001-8018-1523
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
This baseline cross-sectional analysis from data acquired in a sub-sample of the PREDIMED-Plus study participants aimed to evaluate the relation between the Composite Socioeconomic Index (CSI) and lifestyle (diet and physical activity). This study involved 1512 participants (759 (52.2%) women) between 55 and 80 years with overweight/obesity and metabolic syndrome assigned to 137 primary healthcare centers in Catalonia, Spain. CSI and lifestyle (diet and physical activity) were assessed. Multiple linear regression or multinomial regression were applied to the data. Cluster analysis was performed to identify dietary patterns. The multiple linear regression model showed that a high deprivation index was related to a higher consumption of refined cereals (11.98 g/d, p -value = 0.001) and potatoes (6.68 g/d, p -value = 0.001), and to a lower consumption of fruits (-17.52 g/d, p -value = 0.036), and coffee and tea (-8.03 g/d, p -value = 0.013). Two a posteriori dietary patterns were identified by cluster analysis and labeled as "healthy" and "unhealthy". In addition, the multinomial regression model showed that a high deprivation index was related to an unhealthy dietary pattern and low physical activity (OR 1.42 [95% CI 1.06-1.89]; p -value < 0.05). In conclusion, a high deprivation index was related to an unhealthy lifestyle (diet and physical activity) in PREDIMED-Plus study participants.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Granero, Roser|||0000-0001-6308-3198
  • Razquin, C.
  • Corella, D.
  • Gómez-Martínez, C.
  • Castañer-Niño, O.
  • Martínez, J. A.
  • Alonso-Gómez, Á. M.
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, D.
  • López-Miranda, J.
  • Estruch, R.
  • Tinahones, F. J.
  • Lapetra, J.
  • Serra-Majem, J. L.
  • Cano-Ibáñez, N.
  • Tur, J. A.
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, J. J.
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, J.
  • Vázquez, C.
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, E.
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Dalsgaard, S.
  • Garcia-Arellano, A.
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Lassale, C.
  • García-de-la-Hera, M.
  • Gómez-García, E.
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Konieczna, J.
  • Martín Peláez, Sandra|||0000-0002-2193-3913
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Basterra-Gortari, F. J.
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Portoles, O.
  • Muñoz, Miguel-Angel|||0000-0002-4083-3248
  • Arenas-Larriva, A. P.
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Eguaras, Sonia
  • Shyam, S.
  • Fitó, M.
  • Baños, Rosa|||0000-0003-0626-7665
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
To examine the cross-sectional association between baseline depressive symptoms and the presence of type 2 diabetes (T2D), and its association with glycated hemoglobin (HbA1c) and other metabolic variables, and the prospective association of depressive symptoms and HbA1c after 1 year of follow-up. n = 6224 Mediterranean older adults with overweight/obesity and metabolic syndrome (48% females, mean age 64.9 ± 4.9 years) were evaluated in the framework of the PREDIMED-Plus study cohort. Depressive symptoms were assessed using the Beck Depression Inventory-II and HbA1c was used to measure metabolic control. The presence of T2D increased the likelihood of higher levels of depressive symptoms (χ 2 = 15.84, p = 0.001). Polynomial contrast revealed a positive linear relationship (χ 2 = 13.49, p = 0.001), the higher the depressive symptoms levels, the higher the prevalence of T2D. Longitudinal analyses showed that the higher baseline depressive symptoms levels, the higher the likelihood of being within the HbA1c ≥ 7% at 1-year level (Wald-χ 2 = 24.06, df = 3, p < .001, for the full adjusted model). Additionally, depressive levels at baseline and duration of T2D predicted higher HbA1c and body mass index, and lower physical activity and adherence to Mediterranean Diet at 1 year of follow-up. This study supports an association between T2D and the severity of depressive symptoms, suggesting a worse metabolic control from mild severity levels in the short-medium term, influenced by lifestyle habits related to diabetes care. Screening for depressive symptoms and a multidisciplinary integrative therapeutic approach should be ensured in patients with T2D.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Ros, Emilio
  • Basterra Gortari, Francisco Javier
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos Lozano, José Manuel
  • Serra-Majem, Lluis
  • Cano Ibáñez, Noemí
  • Tur, Josep A.
  • Fernández-García, José Manuel
  • Pintó, Xavier
  • Delgado Rodríguez, Miguel
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Fernández-Aranda, Fernando
  • Ruiz Canela, Miguel
  • Mestres Solà, Cristina
  • Portolés, Olga
  • Sala Vila, Aleix
  • García-Ríos, Antonio
  • Compañ-Gabucio, Laura María
  • Gómez-Gracia, Enrique
  • Zulet, María Ángeles
  • Chaplin, Alice
  • Casas, Rosa
  • Martínez Diz, Silvia
  • Tojal-Sierra, Lucas
  • Gómez Pérez, Ana María
  • Toledo, Estefanía
  • Ríos, Santiago
  • Ortega Azorín, Carolina
  • Torre, Rafael de la
  • Peña-Orihuela, Patricia J.
  • García de la Hera, Manuela
  • Sayón-Orea, Carmen
  • Malcampo, Mireia
  • Salas-Salvadó, Jordi
Background: Tree nuts and peanuts (henceforth, nuts) are nutrient-dense foods rich in neuroprotective components; thus, their consumption could benefit cognitive health. However, evidence to date is limited and inconsistent regarding the potential benefits of nuts for cognitive function. Objective: To prospectively evaluate the association between nut consumption and 2-y changes in cognitive performance in older adults at cognitive decline risk. Methods: A total of 6,630 participants aged 55 to 75 y (mean age 65.04.9 y, 48.4% women) with overweight/obesity and metabolic syndrome completed a validated semi-quantitative food frequency questionnaire and a comprehensive battery of neuropsychological tests at baseline and a 2-y follow-up. Composite cognitive scores were used to assess global, general, attention, and executive function domains. Nut consumption was categorized as <1, 1 to <3, 3 to <7, and 7 servings/wk (1 serving¼30 g). Multivariable-adjusted linear regression models were fitted to assess associations between baseline nut consumption and 2-y cognitive changes. Results: Nut consumption was positively associated with 2-y changes in general cognitive function (P-trend <0.001). Compared with participants consuming <1 serving/wk of nuts, those categorized as consuming 3 to <7 and 7 servings/wk showed more favorable changes in general cognitive performance (β z-score [95% CI] ¼ 0.06 [0.00,0.12] and 0.13 [0.06,0.20], respectively). No significant changes were observed in the multivariableadjusted models for other cognitive domains assessed. Conclusion: Frequent nut consumption was associated with a smaller decline in general cognitive performance over 2 y in older adults at risk of cognitive decline. Randomized clinical trials to verify our findings are warranted., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutricion (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS), which is co-funded by the European Regional Development Fund (6 coordinated FIS projects leaded by JS-S and JoV, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/ 00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/ 01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/ 00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/ 00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/ 00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/ 00886, PI20/01158); the Especial Action Project entitled: Implementacion y evaluacion de una intervencion intensiva sobre la actividad física Cohorte PREDIMED-Plus grant and the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the European Research Council (Advanced Research Grant 2014–2019; agreement #340918); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/ 017 and PROMETEO/2021/021 grants from the Consellería de Innovacion, Universidades, Ciencia y Sociedad digital de la Generalitat Valenciana; Grant PID2019-108858RB-I00 funded by AEI 10.13039/ 501100011033 and by “ERDF A way of making Europe”; the SEMERGEN grant; the AICO/2021/347 grants from the Generalitat Valenciana. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2); and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). JN is supported by a predoctoral grant from Ministerio de Ciencia, Innovacion y Universidades (FPU 20/ 00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Adherence to the Mediterranean diet and frailty criteria in an old population with metabolic syndrome: a cross-sectional analysis

  • Torrego Ellacuría, Macarena
  • Cuesta Triana, Federico
  • Ortiz Ramos, María
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Vázquez-Lorente, Héctor
  • Fitó, Montserrat
  • Martínez, José Alfredo
  • Tojal-Sierra, Lucas
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos-Lozano, J. M.
  • Serra-Majem, Lluis
  • Bueno-Cavanillas, A.
  • Tur, Josep A.
  • Romero Vigara, Juan Carlos
  • Pintó, Xavier
  • Gaforio, José J.
  • Vidal, Josep
  • Mas-Fontao, Sebastián
  • Daimiel, Lidia
  • Chiva-Blanch, Gema
  • Basterra Gortari, Francisco Javier
  • Gutierrez, Liliana
  • Sorli, Jose V.
  • Minguella Muñoz, Elisa
  • García-Ríos, Antonio
  • Bernabé Casanova, Andrea
  • Gómez-Gracia, Enrique
  • Zulet, María Ángeles
  • Nafría, Mar
  • Casas, Rosa
  • Garrido-Garrido, Eva M.
  • Goicolea-Güemez, Leire
  • Gómez Pérez, Ana María
  • Ruiz Canela, Miguel
  • Megias, Isabel
  • Valero Barceló, Carmen
  • Montenegro Calvo, Marina
  • Peña-Orihuela, Patricia J.
  • Tercero Marciá, Cristina
  • Razquin, Cristina
  • Babio, Nancy
  • Sala de Vedruna, Adriana
  • Barabash Bustelo, Ana
  • Matía-Martín, Pilar
Objectives: Frailty has emerged as a key indicator of biological aging. This study aimed to assess the relationship between MedDiet adherence and frailty prevalence in the context of metabolic syndrome (MetS). Design: Cross-sectional study. Baseline data from PREDIMED-Plus trial Setting: Primary care health, 23 recruitment sites (2013–2016). Participants: A total of 6874 participants with overweight/obesity and ≥3 MetS components. Measurements: Adherence to the MedDiet: 17-item MedDiet score. Frailty and prefrailty (3 or 1–2 criteria): modified Fried Frailty Index (FFI), considering exhaustion, physical activity and functional capacity. Main independent variable was analysed: as a continuous variable (range: 0–17); in quartiles of adherence using univariate and multivariate logistic regression models adjusted for potential confounders. Results: Prefrailty and frailty prevalence were 49.7% and 2.9%, respectively. Compared to those with the lowest MedDiet adherence (0–6), participants with the highest adherence (11–17) had significantly lower odds of meeting frailty criteria. Fully adjusted models showed ORs of 0.479 (p = 0.097) for frailty, 0.705 (p = 0.001) for prefrailty, and 0.694 (p = 0.001) for frailty or prefrailty in participants with higher/greater MedDiet adherence. Each 1-point increase in the 17-item score was associated with an OR ranging from 0.878 to 0.977 (p < 0.05 for all comparisons, except functional capacity: p = 0.100). When adherence was dichotomized, the adjusted ORs ranged from 0.406 to 0.834 (p < 0.05 for all comparisons). Conclusions: Higher adherence to MedDiet was associated with a lower prevalence of frailty and prefrailty in older adults with overweight/obesity and MetS, reinforcing its potential role in promoting healthy aging despite cardiometabolic comorbidities., This work was supported by official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund(six coordinated FIS projects including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); an NIH grant1R01DK127601, the European Research Council advanced research grant 2014–2019; agreement 340918, and the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant; the Recercaixa grant (2013ACUP00194); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013,PS0358/2016,PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGENgrant; INSA-Ma María de Maeztu Unit of Excellence (grant CEX2021-001234-M funded by MICIN/AEI/FEDER, UE); Juan de la Cierva Research Grant (IJC2019-042420-I/AEI/ 10.13039/501100011033) from Agencia Estatal de Investigación to J.K., and a contract financed by the Government of the Balearic Islands Funds was partially supported by ICREA under the ICREA Academia program; Nutrition Grant from the Sociedad Española de Endocrinología y Nutrición Foundation(FSEEN, 2022) to PMM. HVL was funded by a research grant from the Agència de Gestió d’Ajuts Universitaris de Recerca via Unión Europea, Next Generation EU(AGAUR, record number: 2023POST-INV-01)
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Dairy product consumption and changes in cognitive performance: two-year analysis of the PREDIMED-Plus Cohort

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Gómez-Gracia, Enrique
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra-Majem, Lluis
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Martín-Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Barabash Bustelo, Ana
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Toledo, Estefanía
  • Coltell, Oscar
  • Gómez-Martínez, Carlos
  • Zomeño, María Dolores
  • Donat Vargas, Carolina
  • Goicolea-Güemez, Leire
  • Bouzas, Cristina
  • García de la Hera, Manuela
  • Chaplin, Alice
  • García-Ríos, Antonio
  • Casas, Rosa
  • Cornejo-Pareja, Isabel
  • Santos Lozano, José Manuel
  • Rognoni, Teresa
  • Saiz, Carmen
  • Paz-Graniel, Indira
  • Malcampo, Mireia
  • Sánchez Villegas, María Almudena
  • Salaverria-Lete, Itziar
  • García-Arellano, Ana
  • Schröder, Helmut
  • Salas-Salvadó, Jordi
Scope: Dairy consumption has been suggested to impact cognition; however, evidence is limited and inconsistent. This study aims to longitudinally assess the association between dairy consumption with cognitive changes in an older Spanish population at high cardiovascular disease risk. Methods and results: Four thousand six hundred sixty eight participants aged 55–75 years, completed a validated food frequency questionnaire at baseline and a neuropsychological battery of tests at baseline and 2-year follow-up. Multivariable linear regression models are used, scaled by 100 (i.e., the units of β correspond to 1 SD/100), to assess associations between baseline tertile daily consumption and 2-year changes in cognitive performance. Participants in the highest tertile of total milk and whole-fat milk consumption have a greater decline in global cognitive function (β: –4.71, 95% CI: –8.74 to –0.69, p-trend = 0.020 and β: –6.64, 95% CI: –10.81 to –2.47, p-trend = 0.002, respectively) compared to those in the lowest tertile. No associations are observed between low fat milk, yogurt, cheese or fermented dairy consumption, and changes in cognitive performance. Conclusion:Results suggest there are no clear prospective associations between consumption of most commonly consumed dairy products and cognition, although there may be an association with a greater rate of cognitive decline over a 2-year period in older adults at high cardiovascular disease risk for whole-fat milk., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (six coordinated FIS projects leaded by J.S.-S. and J.Vi., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/ 02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/ 01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/ 00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/ 01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/ 00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S.; the European Research Council (Advanced Research Grant 2014– 2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S.; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 and PROMETEO/2021/021 grants from the Generalitat Valenciana; the SEMERGEN grant; Juan de la Cierva–Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds to JK. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). J.N. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 20/00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). C.G.-M. is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). I.P.-G. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). J.S.-S., senior author of this paper, was partially supported by ICREA under the ICREA Academia program.